Gilead Sciences, Inc. (ETR:GIS)
Germany · Delayed Price · Currency is EUR 102.82
-1.16 (-1.12%)
Jan 12, 2026, 11:23 AM CET
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of €129.17 billion as of January 12, 2026. Its market cap has increased by 15.37% in one year.
Market Cap
129.17B
Enterprise Value
141.51B
Revenue
24.79B
Ranking
n/a
PE Ratio
18.69
Stock Price
€102.82
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 129.17B, an increase of 66,316.87%. That is a compound annual growth rate of 21.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 129.17B | -0.41% |
| Dec 31, 2025 | 129.70B | 16.64% |
| Dec 31, 2024 | 111.19B | 21.76% |
| Dec 29, 2023 | 91.32B | -9.36% |
| Dec 30, 2022 | 100.75B | 25.80% |
| Dec 31, 2021 | 80.09B | 34.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.78B |
| Siemens Healthineers AG | 51.89B |
| Bayer Aktiengesellschaft | 38.20B |
| Fresenius SE & Co. KGaA | 27.73B |
| Sartorius Aktiengesellschaft | 15.77B |
| Fresenius Medical Care AG | 11.04B |
| Fielmann Group AG | 3.67B |
| Carl Zeiss Meditec AG | 3.61B |